Laboratory Corporation of America Holdings (LH) - Total Liabilities
Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) has total liabilities worth $9.55 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Laboratory Corporation of America Holdin operating cash flow efficiency to assess how effectively this company generates cash.
Laboratory Corporation of America Holdings - Total Liabilities Trend (1989–2024)
This chart illustrates how Laboratory Corporation of America Holdings's total liabilities have evolved over time, based on quarterly financial data. Check Laboratory Corporation of America Holdin asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Laboratory Corporation of America Holdings Competitors by Total Liabilities
The table below lists competitors of Laboratory Corporation of America Holdings ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Quest Diagnostics Incorporated
NYSE:DGX
|
USA | $8.94 Billion |
|
Guangdong Songfa Ceramics Co
SHG:603268
|
China | CN¥38.16 Billion |
|
Kuehne & Nagel
SW:KNIN
|
Switzerland | CHF9.73 Billion |
|
Chongqing Sokon Ind Grp Co
SHG:601127
|
China | CN¥92.78 Billion |
|
Royalty Pharma Plc
NASDAQ:RPRX
|
USA | $9.91 Billion |
|
China Everbright Bank Co Ltd
SHG:601818
|
China | CN¥6.65 Trillion |
|
Wipro Limited
F:WIOA
|
Germany | €448.06 Billion |
|
Hapag Lloyd AG
XETRA:HLAG
|
Germany | €11.41 Billion |
Liability Composition Analysis (1989–2024)
This chart breaks down Laboratory Corporation of America Holdings's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Laboratory Corporation of America Holdin stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.23 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Laboratory Corporation of America Holdings's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Laboratory Corporation of America Holdings (1989–2024)
The table below shows the annual total liabilities of Laboratory Corporation of America Holdings from 1989 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $10.31 Billion | +16.73% |
| 2023-12-31 | $8.83 Billion | -12.00% |
| 2022-12-31 | $10.04 Billion | -0.51% |
| 2021-12-31 | $10.09 Billion | -4.93% |
| 2020-12-31 | $10.61 Billion | +1.48% |
| 2019-12-31 | $10.46 Billion | +13.75% |
| 2018-12-31 | $9.19 Billion | -6.63% |
| 2017-12-31 | $9.85 Billion | +12.86% |
| 2016-12-31 | $8.73 Billion | -4.58% |
| 2015-12-31 | $9.14 Billion | +104.87% |
| 2014-12-31 | $4.46 Billion | -0.11% |
| 2013-12-31 | $4.47 Billion | +10.14% |
| 2012-12-31 | $4.06 Billion | +11.23% |
| 2011-12-31 | $3.65 Billion | +2.66% |
| 2010-12-31 | $3.55 Billion | +36.07% |
| 2009-12-31 | $2.61 Billion | -8.70% |
| 2008-12-31 | $2.86 Billion | +8.21% |
| 2007-12-31 | $2.64 Billion | +30.60% |
| 2006-12-31 | $2.02 Billion | +1.69% |
| 2005-12-31 | $1.99 Billion | +22.33% |
| 2004-12-31 | $1.63 Billion | +7.10% |
| 2003-12-31 | $1.52 Billion | +56.81% |
| 2002-12-31 | $968.70 Million | +14.75% |
| 2001-12-31 | $844.20 Million | +6.93% |
| 2000-12-31 | $789.50 Million | -7.77% |
| 1999-12-31 | $856.00 Million | -10.81% |
| 1998-12-31 | $959.70 Million | -6.69% |
| 1997-12-31 | $1.03 Billion | -38.00% |
| 1996-12-31 | $1.66 Billion | +16.37% |
| 1995-12-31 | $1.43 Billion | +68.37% |
| 1994-12-31 | $846.70 Million | +90.40% |
| 1993-12-31 | $444.70 Million | +67.87% |
| 1992-12-31 | $264.90 Million | +229.07% |
| 1991-12-31 | $80.50 Million | -31.49% |
| 1990-12-31 | $117.50 Million | +207.59% |
| 1989-12-31 | $38.20 Million | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and… Read more